An effect-size analysis of the relative efficacy and tolerability of serotonin selective reuptake inhibitors for panic disorder.
about
Antidepressants and benzodiazepines for panic disorder in adultsAntidepressants versus placebo for panic disorder in adultsPrevalence of attention deficit/hyperactivity disorder among adults in obesity treatmentPropranolol for the treatment of anxiety disorders: Systematic review and meta-analysisCanadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disordersEmerging drugs for the treatment of anxietyThe efficacy of paroxetine and placebo in treating anxiety and depression: a meta-analysis of change on the Hamilton Rating ScalesAdvances in the treatment of anxiety: targeting glutamate.Indirect comparisons: a review of reporting and methodological qualityPsychopharmacology of anxiety disorders.The role of alprazolam for the treatment of panic disorder in Australia.Panic-focused psychodynamic psychotherapy in a woman with panic disorder and generalized anxiety disorder.Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology.Cannabidiol as a Potential Treatment for Anxiety Disorders.Pharmacotherapy of anxiety disorders: a critical reviewLifestyle Behaviours Add to the Armoury of Treatment Options for Panic Disorder: An Evidence-Based Reasoning.Venlafaxine extended release (XR) in the treatment of panic disorder.Management of panic disorder.Paroxetine in panic disorder: clinical management and long-term follow-up.Mood and anxiety disorders in chronic headache.Pharmacological management of panic disorder.Treatment of panic disorder: recent developments and current status.Treatment of comorbid anxiety and autism spectrum disordersPsychiatric treatment received by primary care patients with panic disorder with and without agoraphobia.New treatment options for panic disorder: clinical trials from 2000 to 2010.Evidence-based pharmacotherapy of panic disorder: an update.The diagnostic value of clinical EEG in detecting abnormal synchronicity in panic disorder.Antidepressants and benzodiazepines for panic disorder in adults.SSRIs vs. TCAs in the treatment of panic disorder: a meta-analysis.Australian and New Zealand clinical practice guidelines for the treatment of panic disorder and agoraphobia.An effect-size analysis of pharmacologic treatments for generalized anxiety disorder.Does cognitive behavioral therapy alter mental defeat and cognitive flexibility in patients with panic disorder?
P2860
Q24187763-46E74C6C-EAAD-4F42-B25E-2412F746ED0FQ24201481-69D8C09B-456E-4D7E-86FF-8281544CE4CCQ24791399-33446CF7-742C-4007-B753-3C6A1AC420A4Q26781133-3A546B3D-B9C8-45B7-AC2C-0A90D5EEB258Q27009995-4F58AFC7-796B-45B1-8693-062AD65A386CQ28083141-6468F65B-EB97-4FA8-A974-942E86921FC2Q28542596-65022FF2-3F4A-47F2-B212-945C46D49A31Q30457479-350629E2-083A-4D4E-AD46-B934AA248576Q33750311-77907CD0-DA79-45F3-AC89-A99334AF9B01Q34228150-435ACB4E-F669-4A99-929D-CC29E4AB85F5Q34258725-E52A6947-45D1-4AD8-A863-FD02C7C78227Q34303419-6BFDB4A8-CE9B-4F3F-A71D-FB1C77337F1EQ34465555-CE51114A-0B51-493E-80D5-9C449C911B7BQ34492624-16E35FC9-4D1D-4402-9A85-E88C0B8E3EC6Q35686859-8DAA123B-7540-4C88-9D59-3C6A6C0791DAQ35791127-A85FBE2B-9F6E-4215-9180-6EB6266965F4Q35919158-BAE6B069-7AC7-4553-86DE-2ED4F3473F7EQ36106827-CAFB79BE-1FBA-471A-9440-DE075D067D9CQ36107073-CB4A856B-0272-4A83-B797-62A8035DE000Q36620677-75FDE17B-A326-4B83-AC11-52EB7358446CQ36836798-20BA2D8E-947E-4811-AEB5-C39113A5FF00Q37232022-1032D105-506B-4685-BD3F-E8CC46137ED9Q37257081-276247DA-7B19-407C-B256-3979B5ED9B32Q37317616-AB8035DE-5BAC-4135-BB17-4BD4B3EB8548Q37845855-306DC03C-E3EB-4397-ACD8-7FAD2666BDCEQ37898209-80FE9CA1-D021-4F38-B173-0720AE24955FQ37922727-7A4F88FC-20D1-46D0-9CEB-7D02B3D67116Q38952014-CD06DACE-1E1C-43DA-A63C-4C406CB317F1Q44115958-35F405B8-5EB5-46BF-88B5-81E17BFCE9E4Q44667926-2E73D209-0331-43E7-A184-53C34D728D8AQ46913592-6F17B15F-F01A-4303-B494-93B10F358630Q47556429-2EF0137D-A904-45B1-900F-66B4F27D226D
P2860
An effect-size analysis of the relative efficacy and tolerability of serotonin selective reuptake inhibitors for panic disorder.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
An effect-size analysis of the ...... inhibitors for panic disorder.
@en
An effect-size analysis of the ...... inhibitors for panic disorder.
@nl
type
label
An effect-size analysis of the ...... inhibitors for panic disorder.
@en
An effect-size analysis of the ...... inhibitors for panic disorder.
@nl
prefLabel
An effect-size analysis of the ...... inhibitors for panic disorder.
@en
An effect-size analysis of the ...... inhibitors for panic disorder.
@nl
P2093
P1476
An effect-size analysis of the ...... inhibitors for panic disorder
@en
P2093
P304
P356
10.1176/APPI.AJP.158.12.1989
P407
P577
2001-12-01T00:00:00Z